Acropolis Infrastructure Acquisition (ACRO) 10-Q 23 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Aug. 23, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Entity File Number	001-40584
Entity Registrant Name	ACROPOLIS INFRASTRUCTURE ACQUISITION CORP.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-2120451
Entity Address, Address Line One	9 West 57th Street, 43rd Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10019
City Area Code	212
Local Phone Number	515-3200
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001847891
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false
Transition Report	false
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one public warrant
Trading Symbol	ACRO.U
Security Exchange Name	NYSE
Class A Common Stock
Document Information [Line Items]
Title of 12(b) Security	Shares of Class A common stock included as part of the units
Trading Symbol	ACRO
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		30,000,000
Warrants Included as Part Of Units
Document Information [Line Items]
Title of 12(b) Security	Warrants included as part of the units
Trading Symbol	ACRO WS
Security Exchange Name	NYSE
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		8,625,000

CONDENSED BALANCE SHEET

CONDENSED BALANCE SHEET - USD ($)		Jun. 30, 2021	Dec. 31, 2020
Current assets:
Current assets - Cash		$ 25,000
Due from Sponsor			$ 25,000
Deferred offering costs		1,205,487	57,900
Total assets		1,230,487	82,900
Current liabilities:
Current liabilities - Accrued offering costs		1,041,011	57,900
Advances from related party		164,476
Total liabilities		1,205,487	57,900
Commitments and contingencies (Note 6):
Stockholders' equity:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital		24,602	24,602
Accumulated deficit		(465)	(465)
Total stockholders' equity		25,000	25,000
Total liabilities and stockholders' equity		1,230,487	82,900
Class B Common Stock
Stockholders' equity:
Common stock	[1]	863	863
Total stockholders' equity	[2],[3]	$ 863	$ 863
[1]	Includes an aggregate of up to 1,125,000 shares of Class B common stock that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter (see Note 5).The over-allotment option was exercised in full in August 2021 and thus, these shares are no longer subject to forfeiture (see Notes 5 and 9).
[2]	Includes an aggregate of up to 1,125,000 shares of Class B common stock that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter (see Note 5). The over-allotment option was exercised in full in August 2021 and thus, these shares are no longer subject to forfeiture (see Notes 5 and 9).
[3]	Share amounts at December 31, 2020 have been retroactively restated to account for the stock reclassification as discussed in Note 5.

CONDENSED BALANCE SHEET (Parent

CONDENSED BALANCE SHEET (Parenthetical) - $ / shares	Aug. 31, 2021	Aug. 03, 2021	Jun. 30, 2021	Dec. 31, 2020
Preferred stock, par value, (per share)			$ 0.0001	$ 0.0001
Preferred stock, shares authorized			1,000,000	1,000,000
Preferred stock, shares issued			0	0
Preferred stock, shares outstanding			0	0
Over-allotment option
Purchase price, per unit		$ 10	$ 10
Class A Common Stock
Common shares, shares authorized			800,000,000	800,000,000
Common shares, shares issued			8,625,000
Common shares, shares outstanding			8,625,000
Class A Common Stock Not Subject to Redemption
Common shares, par value, (per share)			$ 0.0001	$ 0.0001
Common shares, shares authorized			800,000,000	800,000,000
Common shares, shares issued			0	0
Common shares, shares outstanding			0	0
Class B Common Stock
Common shares, par value, (per share)			$ 0.0001	$ 0.0001
Common shares, shares authorized			199,000,000	199,000,000
Common shares, shares issued			8,625,000	8,625,000
Common shares, shares outstanding			8,625,000	8,625,000
Class B Common Stock | Over-allotment option
Temporary equity, shares outstanding	1,125,000
Common stock subject to redemption
Temporary equity, shares outstanding			1,125,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)		3 Months Ended	6 Months Ended
		Jun. 30, 2021	Jun. 30, 2021
CONDENSED STATEMENTS OF OPERATIONS
REVENUE		$ 0	$ 0
Formation and operating costs		0	0
Other income:
Net loss		$ 0	$ 0
Weighted average shares outstanding, basic and diluted(1)	[1]	8,625,000	8,625,000
Basic and diluted net loss per share		$ 0	$ 0
[1]	This number excludes up to 1,125,000 shares of Class B common stock that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5). The over-allotment option was exercised in full in August 2021 and thus, these shares are no longer subject to forfeiture (see Notes 5 and 9).

CONDENSED STATEMENTS OF OPERA_2

CONDENSED STATEMENTS OF OPERATIONS (Parenthetical)	Aug. 31, 2021shares
Class B Common Stock | Over-allotment option
Temporary equity, shares outstanding	1,125,000

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)		Class B Common Stock		Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020		$ 863	[1],[2]	$ 24,602	$ (465)	$ 25,000
Balance at the beginning (in shares) at Dec. 31, 2020	[1],[2]	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ 0	[1],[2]	0	0	0
Balance at the end (in shares) at Mar. 31, 2021	[1],[2]	8,625,000
Balance at the beginning at Dec. 31, 2020		$ 863	[1],[2]	24,602	(465)	25,000
Balance at the beginning (in shares) at Dec. 31, 2020	[1],[2]	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsors						$ 25,000
Issuance of Class B common stock to Sponsors (in shares)						34,500,000
Offering costs						$ (1,205,487)
Net loss						0
Balance at the end at Jun. 30, 2021		$ 863	[1],[2]	24,602	(465)	25,000
Balance at the end (in shares) at Jun. 30, 2021	[1],[2]	8,625,000
Balance at the beginning (in shares) at Mar. 31, 2021	[1],[2]	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ 0	[1],[2]	0	0	0
Balance at the end at Jun. 30, 2021		$ 863	[1],[2]	$ 24,602	$ (465)	$ 25,000
Balance at the end (in shares) at Jun. 30, 2021	[1],[2]	8,625,000
[1]	Includes an aggregate of up to 1,125,000 shares of Class B common stock that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter (see Note 5). The over-allotment option was exercised in full in August 2021 and thus, these shares are no longer subject to forfeiture (see Notes 5 and 9).
[2]	Share amounts at December 31, 2020 have been retroactively restated to account for the stock reclassification as discussed in Note 5.

CONDENSED STATEMENTS OF CHANG_2

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - shares	Aug. 03, 2021	Jul. 13, 2021	Jun. 30, 2021	Aug. 31, 2021
Sale of Units, net of underwriting discounts (in shares)		30,000,000
Private Placement Warrants
Sale of Units, net of underwriting discounts (in shares)			5,235,000
Over-allotment option
Sale of Units, net of underwriting discounts (in shares)	4,500,000		4,500,000
Over-allotment option | Private Placement Warrants
Sale of Units, net of underwriting discounts (in shares)	600,000		600,000
Private Placement | Private Placement Warrants
Sale of Private Placement Warrants (in shares)			5,235,000
Class B Common Stock | Over-allotment option
Temporary equity, shares outstanding				1,125,000

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS	6 Months Ended
	Jun. 30, 2021USD ($)
Cash Flows From Operating Activities:
Net loss	$ 0
Net Cash Used In Operating Activities	0
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(5,000,001)
Cash Flows From Financing Activities:
Sponsor payment of receivable	25,000
Net Cash Provided By Financing Activities	25,000
Net change in cash	25,000
Cash at Beginning of Period	0
Cash at End of Period	25,000
Supplemental Schedule of Non-Cash Financing Activities:
Deferred offering costs included in accrued offering costs	1,171,277
Deferred offering costs paid by related party	$ 164,476

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2021
Description of Organization and Business Operations
Description of Organization and Business Operations	1. Description of Organization and Business Operations Organization and General Acropolis Infrastructure Acquisition Corp. (formerly known as AP Caps III, Corp) (the “Company”) was incorporated in the State of Delaware on August 27, 2020 under the name of AP Caps III, Corp. The Company was formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Initial Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). On February 22, 2021, the Company formally changed its name to Apollo Infrastructure Acquisition Corp. On February 23, 2021, the Company formally changed its name to Acropolis Infrastructure Acquisition Corp. The Company has chosen December 31 st At June 30, 2021, the Company had not commenced any operations. All activity for the period from August 27, 2020 through June 30, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after completion of its Initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the net proceeds derived from the Initial Public Offering. Sponsor and Initial Public Offering The Company’s sponsor is Acropolis Infrastructure Acquisition Sponsor, L.P., a Cayman Islands exempted limited partnership (the “Sponsor”). The Company intends to finance its Initial Business Combination with proceeds from the $300,000,000 Initial Public Offering of Units (as defined below) ($345,000,000 upon the underwriters’ exercise in full of their over-allotment option) (Note 3) and a $7,852,500 private placement ($8,700,000 upon the underwriters’ exercise in full of their over-allotment option) (Note 4). Upon the closing of the Initial Public Offering and the private placement, $300,000,000 was placed in a trust account ($345,000,000 upon the underwriters’ exercise in full of their over-allotment option) (the “Trust Account”) (discussed below). On July 13, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the shares of the Company’s Class A common stock, $0.0001 par value per share, included in the Units, the “Public Shares”) generating gross proceeds of $300,000,000 which is described in Note 3. The Sponsor purchased an aggregate of 5,235,000 warrants (the “Private Placement Warrants”) at a purchase price of $1.50 per warrant, or approximately $7,852,500 in the aggregate, in a private placement simultaneously with the closing of the Initial Public Offering (the “Private Placement”). The Private Placement Warrants are included in additional paid-in capital on the condensed balance sheet. On August 3, 2021, the Company consummated the sale of 4,500,000 over-allotment Units pursuant to the underwriters’ exercise of their over-allotment option. Such over-allotment Units were sold at $10.00 per Unit, generating gross proceeds of $45,000,000. Substantially concurrently with the closing of the sale of the over-allotment Units, the Company consummated the private sale of an additional 600,000 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant to the Sponsor, generating gross proceeds of $900,000. Following the closing of the over-allotment option and sale of additional Private Placement Warrants (together, the “Over-Allotment Closing”), a total of $345,000,000, including approximately $12,075,000 of the underwriters’ deferred discount (the “Deferred Discount”), was placed in the Trust Account. As a result of the underwriters’ election to fully exercise their over-allotment option, 1,125,000 Founder Shares (as defined in Note 5) are no longer subject to forfeiture. The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through the Initial Public Offering of 34,500,000 Units at $10.00 per Unit, which is discussed in Note 3 and the sale of 5,835,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a Private Placement, as a result of the underwriters’ exercise of the over-allotment option. Trust Account The proceeds held in the Trust Account will be invested only in U.S. government securities with a maturity of one hundred eighty-five (185) days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, and that invest only in direct U.S. government treasury obligations, as determined by the Company. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Initial Business Combination or (ii) the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay its tax obligations (the “Permitted Withdrawals”), and up to Initial Business Combination The Initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the Deferred Discount and commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the Initial Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect an Initial Business Combination. The Company, after signing a definitive agreement for an Initial Business Combination, will either (i) seek stockholder approval of the Initial Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their Public Shares, regardless of whether they vote for or against the Initial Business Combination, for cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to make Permitted Withdrawals, or (ii) provide stockholders with the opportunity to sell their Public Shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to make Permitted Withdrawals. The decision as to whether the Company will seek stockholder approval of the Initial Business Combination or will allow stockholders to sell their Public Shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval, unless a vote is required by law or under New York Stock Exchange (“NYSE”) rules. If the Company seeks stockholder approval, it will complete its Initial Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Initial Business Combination, subject to any greater or additional vote required by applicable law or any rule or regulation applicable to the Company or its securities. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Initial Business Combination, and instead may search for an alternate Initial Business Combination. If the Company holds a stockholder vote or there is a tender offer for shares in connection with an Initial Business Combination, a stockholder will have the right to redeem his, her or its Public Shares for an amount in cash equal to his, her or its pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to make Permitted Withdrawals. As a result, such Public Shares are recorded at redemption amount and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “ Distinguishing Liabilities from Equity Pursuant to the Company’s amended and restated certificate of incorporation, if the Company is unable to complete the Initial Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to make Permitted Withdrawals (less up to $100,000 of such net interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined in Note 5) held by them if the Company fails to complete the Initial Business Combination within the Completion Window. However, if the Sponsor or any of the Company’s directors, officers or affiliates acquire shares of Class A common stock in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the Initial Business Combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the Company after an Initial Business Combination, the Company’s stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of common stock, if any, having preference over the common stock. The Company’s stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the common stock, except that the Company will provide its stockholders with the opportunity to redeem their Public Shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, upon the completion of the Initial Business Combination, subject to the limitations described herein. Liquidity At June 30, 2021, the Company had cash of $25,000 and a working capital deficit of $1,180,487. On July 13, 2021, the Company closed its Initial Public Offering of 30,000,000 Units at $10.00 per Unit, generating gross proceeds of $300 million. Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,235,000 Private Placement Warrants to the Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds of $7,852,500. On August 3, 2021, the Company consummated the sale of 4,500,000 over-allotment Units pursuant to the underwriters’ exercise of their over-allotment option. Such over-allotment Units were sold at $10.00 per Unit, generating gross proceeds of $45,000,000. Substantially concurrently with the closing of the sale of the over-allotment Units, the Company consummated the private sale of an additional 600,000 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant to the Sponsor, generating gross proceeds of $900,000. The Company held $559,752 outside of the Trust Account upon the closing of the Initial Public Offering and the Over-Allotment Closing. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through a payment of $25,000 of certain deferred offering costs on the Company’s behalf by the Sponsor in exchange for the issuance of the Founder Shares and the proceeds of a loan of $300,000 under an unsecured and noninterest bearing promissory note (see Note 5). Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity will be satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with an Initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Working Capital Loans (as defined in Note 5).

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	2. Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had cash of $25,000 and $0 Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account. Deferred Offering Costs associated with the Initial Public Offering The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “ Expenses of Offering Fair Value of Financial Instrument The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “ Fair Value Measurement Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets. Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3 Inputs: Significant inputs into the valuation model are unobservable. The Company does not have any recurring Level 2 or Level 3 assets or liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “ Derivatives and Hedging (ASC 815)”. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” The provision for income taxes was deemed to be de minimis for the three and six months ended June 30, 2021. The Company’s deferred tax assets were deemed to be de minimis as of June 30, 2021 and December 31, 2020. ​ Net Loss Per Share of Common Stock Net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of common stock outstanding during the period, plus, to the extent dilutive, the incremental number of shares of common stock to settle warrants, as calculated using the treasury stock method. At June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method. As a result, diluted loss per share of common stock is the same as basic loss per share of common stock for the period presented. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s interim condensed financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2021
Initial Public Offering.
Initial Public Offering	3. Pursuant to the Initial Public Offering, the Company sold 30,000,000 Units at a price of $10.00 per unit. Each Unit consists of one share of Class A common stock and one

Private Placement

Private Placement	6 Months Ended
	Jun. 30, 2021
Private Placement.
Private Placement	4. Private Placement Concurrently with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 5,235,000 Private Placement Warrants ($7,852,500 in the aggregate) in a Private Placement. Concurrently with the closing of the sale of the over-allotment Units on August 3, 2021, the Company consummated the private sale of an additional 600,000 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant to the Sponsor, generating gross proceeds of $900,000. Each whole Private Placement Warrant is exercisable for one whole share of the Company’s Class A common stock at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Initial Business Combination is not completed within the Completion Window, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable and exercisable on a cashless basis. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions
Related Party Transactions	5. Related Party Transactions Founder Shares The Company was formed in August 2020. In August 2020, Acropolis Infrastructure Acquisition Sponsor, L.P. subscribed for 1,990 shares of the Company’s Class B common stock for $19.90.Acropolis Infrastructure Acquisition Sponsor, L.P. distributed the shares to Apollo Principal Holdings III, L.P. in December 2020. Apollo Principal Holdings III, L.P. then distributed the shares to Acquisition Sponsor, L.P. on March 16, 2021. On February 22, 2021, the Company completed a stock reclassification of its Class B common stock and, as a result, 11,500,000 shares of the Company’s shares of Class B common stock were outstanding (the “Founder Shares”). On March 31, 2021, 50,000 Founder Shares were purchased from the Sponsor by each of the three independent director nominees at a purchase price of approximately $0.002 per share. The independent director nominees paid $300 in aggregate for 150,000 shares. In June 2021, the Sponsor forfeited 2,875,000 Founder Shares and, as a result, 8,625,000 shares of the Company’s Founder Shares were outstanding. The share amounts as of June 30, 2021 have been retroactively restated to account for the forfeiture. The Founder Shares are identical to the shares of Class A common stock included in the Units sold in the Initial Public Offering except that the Founder Shares are shares of Class B common stock which automatically convert into shares of Class A common stock at the time of the Company’s Initial Business Combination and are subject to certain transfer restrictions, as described in more detail below. The number of Founder Shares issued in the share split was determined based on the expectation that the total size of the Initial Public Offering would be a maximum of 34,500,000 Units if the underwriters’ over-allotment option was exercised in full, and therefore that such Founder Shares would represent 20% of the issued and outstanding common stock after the Initial Public Offering. The holders of the Founder Shares agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last reported sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 - trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Due from Sponsor At December 31, 2020, the Company had $25,000 due from the Sponsor, which represented the remaining amount owed in exchange for the issuance of Class B common stock to the Sponsor which will be fully funded by the Sponsor. The amount was paid to the Company by the Sponsor in March 2021. Related Party Loans On February 24, 2021, the Sponsor agreed to loan the Company an aggregate of up to $750,000 to cover expenses related to the Initial Public Offering pursuant to an unsecured promissory note (the “Note”). This Note bore interest at a rate of 0.12% per annum and was payable on the earlier of December 31, 2021 or the closing date of the Initial Public Offering. As of June 30, 2021, the Company had not borrowed on the Note. The Note expired upon consummation of the Initial Public Offering. Advances from Related Party An affiliate of the Sponsor paid certain formation and operating costs on behalf of the Company. During the period of August 27, 2020 (inception) through December 31, 2020, the related party paid $465 of formation and operating expenses on behalf of the Company which were recorded as contributed capital in the accompanying interim condensed financial statements. During the six months ended June 30, 2021, the related party paid certain Initial Public Offering costs totaling $164,476 on behalf of the Company. As of June 30, 2021, $164,476 was due to the related party. Administrative Support Agreement Commencing on the date the Units are first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $16,667 per month for office space, utilities and secretarial and administrative support for up to 27 months. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. ​

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies
Commitments and Contingencies	6. Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants and Warrants that may be issued upon conversion of working capital loans, if any, (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and Warrants that may be issued upon conversion of working capital loans) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to demand that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of an Initial Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 30 The underwriters are entitled to a Deferred Discount of $0.35 per Unit. The Deferred Discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement. On August 3, 2021, the Company consummated the sale of 4,500,000 over-allotment Units pursuant to the underwriters’ exercise of their over-allotment option, as a result of which the underwriters are entitled to an aggregate Deferred Discount of $12,075,000. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these interim condensed financial statements. The interim condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Stockholders' Equity
Stockholder's Equity	7. Preferred Stock The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding. Common Stock The authorized shares of common stock of the Company include 800,000,000 shares of Class A common stock with a par value of $0.0001 per share and 199,000,000 shares of Class B common stock with a par value of $0.0001 per issued The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of completion of the Initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to the closing of the Initial Business Combination, the ratio at which shares of Class B common stock will convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of this offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the Initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Initial Business Combination). Warrants Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of an Initial Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of an Initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the public warrant agreement. Notwithstanding the foregoing, if the Company’s shares of common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option, may require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon the Company’s redemption or liquidation. The Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption; and ● if, and only if, the last reported closing price of the Company’s shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period ending three business days prior to the date on which the Company sends the notice of redemption to the warrant holders. ● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and a current prospectus relating to those shares of common stock is available throughout the 30-day trading period referred to above. ​ If the Company calls the Public Warrants for redemption as described above, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis period,” as will be described in the Public Warrant agreement. The exercise price and number of the shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of shares of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete an Initial Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable and will be exercisable at the election of the holder on a “cashless basis.” Neither the Private Placement Warrants nor Public Warrants contain any provisions that change dependent upon the characteristics of the holder of the warrant.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events
Subsequent Events	8. Subsequent Events Management has evaluated subsequent events to determine if events or transactions occurring after the balance sheet date through August 23 2021, require potential adjustment to or disclosure in the interim condensed financial statements. Management did not identify any other subsequent events that would have required adjustment or disclosure in the interim condensed financial statements. On July 27, 2021, the Sponsor agreed to loan the Company an aggregate of up to $1,200,000 to cover costs and expenses related to the Company’s operating expenses or initial business combination pursuant to an unsecured promissory note. This note bears interest at a rate of 0.12% per annum and is payable on the earlier of date on which the Company consummates an Initial Business Combination or the liquidation of the Company. On August 20, 2021, the Sponsor agreed to loan the Company an aggregate of up to $800,000 to cover costs and expenses related to the Company’s operating expenses or initial business combination pursuant to an unsecured promissory note. This note bears interest at a rate of 0.14% per annum and is payable on the earlier of date on which the Company consummates an Initial Business Combination or the liquidation of the Company.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020, the Company had cash of $25,000 and $0
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” The provision for income taxes was deemed to be de minimis for the three and six months ended June 30, 2021. The Company’s deferred tax assets were deemed to be de minimis as of June 30, 2021 and December 31, 2020.
Deferred Offering Costs associated with the Initial Public Offering	Deferred Offering Costs associated with the Initial Public Offering The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “ Expenses of Offering
Net Loss Per Share of Common Stock	Net Loss Per Share of Common Stock Net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of common stock outstanding during the period, plus, to the extent dilutive, the incremental number of shares of common stock to settle warrants, as calculated using the treasury stock method. At June 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method. As a result, diluted loss per share of common stock is the same as basic loss per share of common stock for the period presented.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.
Fair Value of Financial Instrument	Fair Value of Financial Instrument The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “ Fair Value Measurement Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets. Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3 Inputs: Significant inputs into the valuation model are unobservable. The Company does not have any recurring Level 2 or Level 3 assets or liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “ Derivatives and Hedging (ASC 815)”.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s interim condensed financial statements.

Description of Organization a_2

Description of Organization and Business Operations (Details)

Oct. 31, 2021USD ($)

Aug. 20, 2021USD ($)

Aug. 03, 2021USD ($)$ / sharesshares

Jul. 27, 2021USD ($)

Jul. 13, 2021USD ($)$ / sharesshares

Mar. 31, 2021$ / sharesshares

Feb. 24, 2021USD ($)

Oct. 31, 2020USD ($)$ / shares

Oct. 14, 2020item

Aug. 31, 2020shares

Jun. 30, 2022USD ($)

Jun. 30, 2021USD ($)$ / sharesshares

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

30,000,000

Proceeds from issuance initial public offering

$ 300,000,000

Number of shares issued | shares

34,500,000

Cash held outside the Trust Account

$ 25,000

Securities Held In Trust Account

25,000

Working Capital

1,180,487

Aggregate purchase price

25,000

Proceeds from Related Party Debt

$ 750,000

Condition for future business combination number of businesses minimum | item

1

Payments for investment of cash in Trust Account

$ 5,000,001

Redemption limit percentage without prior consent

100

Maximum Allowed Dissolution Expenses

$ 100,000

Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

5,235,000

Purchase price, per unit | $ / shares

$ 1.50

Proceeds from issuance initial public offering

$ 900,000

Proceeds from sale of Private Placement Warrants

$ 7,852,500

Proceeds from issuance of warrants

$ 7,852,500

Subsequent Event [Member]

Subsidiary, Sale of Stock [Line Items]

Proceeds from issuance initial public offering

$ 45,000,000

Initial Public Offering

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

30,000,000

Purchase price, per unit | $ / shares

$ 10

$ 1.50

Proceeds from issuance initial public offering

$ 300,000,000

$ 300,000,000

Cash held outside the Trust Account

100,000

Payments for investment of cash in Trust Account

$ 10

Proceeds From Issuance Of Initial Pubic offering Including Exercise Of Overallotment Option

$ 345,000,000

Initial Public Offering | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Percentage of redemption required if business combination is not completed by specified date

100

Redemption of shares calculated based on business period prior to consummation of business combination

24 months

Redemption period upon closure

27 months

Private Placement

Subsidiary, Sale of Stock [Line Items]

Number of shares issued | shares

5,835,000

Proceeds From Issuance Of Initial Pubic offering Including Exercise Of Overallotment Option

$ 8,700,000

Private Placement | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Sale of Private Placement Warrants (in shares) | shares

5,235,000

Price of warrant | $ / shares

$ 1.50

$ 11.50

Proceeds from sale of Private Placement Warrants

$ 900,000

$ 7,852,500

Number of warrants issued | shares

5,235,000

Proceeds from issuance of warrants

$ 900,000

$ 7,852,500

Over-allotment option

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

4,500,000

4,500,000

Purchase price, per unit | $ / shares

$ 10

$ 10

Proceeds from issuance initial public offering

$ 45,000,000

Cash held outside the Trust Account

$ 559,752

Over-allotment option | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

600,000

600,000

Purchase price, per unit | $ / shares

$ 1.50

Proceeds from issuance initial public offering

$ 900,000

Over-allotment option | Subsequent Event [Member]

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

4,500,000

Purchase price, per unit | $ / shares

$ 10

Underwriters' deferred discount

$ 12,075,000

Sponsor

Subsidiary, Sale of Stock [Line Items]

Proceeds from Related Party Debt

$ 300,000,000,000

Sponsor | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

5,235,000

Warrants purchase Price | $ / shares

$ 1.50

Sponsor | Subsequent Event [Member]

Subsidiary, Sale of Stock [Line Items]

Proceeds from Related Party Debt

$ 800,000

$ 1,200,000

Sponsor | Subsequent Event [Member] | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Sale of Private Placement Warrants (in shares) | shares

600,000

5,235,000

Price of warrant | $ / shares

$ 1.50

$ 1.50

Number of warrants issued | shares

600,000

5,235,000

Sponsor | Initial Public Offering | Subsequent Event [Member]

Subsidiary, Sale of Stock [Line Items]

Proceeds from issuance initial public offering

$ 300,000,000

Sale of Private Placement Warrants (in shares) | shares

30,000,000

Price of warrant | $ / shares

$ 0.0001

Number of warrants issued | shares

30,000,000

Sponsor | Private Placement

Subsidiary, Sale of Stock [Line Items]

Proceeds from issuance initial public offering

$ 7,852,500

Sponsor | Private Placement | Subsequent Event [Member] | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Proceeds from sale of Private Placement Warrants

$ 7,852,500

Proceeds from issuance of warrants

$ 7,852,500

Sponsor | Over-allotment option | Subsequent Event [Member]

Subsidiary, Sale of Stock [Line Items]

Number of units sold | shares

4,500,000

Purchase price, per unit | $ / shares

$ 10

Proceeds from issuance initial public offering

$ 45,000,000

Investment Of Proceeds In Trust Account

$ 345,000,000

Shares Subject To Forfeiture | shares

1,125,000

Underwriting fees

$ 12,075,000

Sponsor | Over-allotment option | Subsequent Event [Member] | Private Placement Warrants

Subsidiary, Sale of Stock [Line Items]

Proceeds from issuance initial public offering

$ 900,000

Sponsor | Founder Shares

Subsidiary, Sale of Stock [Line Items]

Purchase price, per unit | $ / shares

$ 0.002

Number of shares issued | shares

50,000

1,990

Number of shares subject to forfeiture | shares

2,875,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Aug. 03, 2021	Jul. 13, 2021	Oct. 31, 2020	Jun. 30, 2021	Dec. 31, 2020
Cash				$ 25,000	$ 712,000
Cash equivalents				0	0
Unrecognized tax benefits				0	0
Unrecognized tax benefits accrued for interest and penalties				0	0
Units Issued During Period, Shares, New Issues		30,000,000
Proceeds from issuance initial public offering		$ 300,000,000
Offering costs				$ 1,205,487	$ 57,900
Initial Public Offering
Units Issued During Period, Shares, New Issues				30,000,000
Proceeds from issuance initial public offering			$ 300,000,000	$ 300,000,000
Purchase price, per unit		$ 10	$ 1.50
Over-allotment option
Units Issued During Period, Shares, New Issues	4,500,000			4,500,000
Proceeds from issuance initial public offering	$ 45,000,000
Purchase price, per unit	$ 10			$ 10
Private Placement Warrants
Units Issued During Period, Shares, New Issues				5,235,000
Proceeds from issuance initial public offering				$ 900,000
Purchase price, per unit				$ 1.50
Private Placement Warrants | Over-allotment option
Units Issued During Period, Shares, New Issues	600,000			600,000
Proceeds from issuance initial public offering	$ 900,000
Exercise price of warrants				$ 1.50
Purchase price, per unit	$ 1.50
Public Warrants | Initial Public Offering
Exercise price of warrants				$ 11.50
Number of shares issuable per warrant				1
Number of shares in a unit				1
Number of warrants in a unit				0.5

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Aug. 03, 2021	Jul. 13, 2021	Oct. 31, 2020	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Number of units sold		30,000,000
Proceeds from issuance initial public offering		$ 300,000,000
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units sold				5,235,000
Purchase price, per unit				$ 1.50
Proceeds from issuance initial public offering				$ 900,000
Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	$ 45,000,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units sold				30,000,000
Purchase price, per unit		$ 10	$ 1.50
Proceeds from issuance initial public offering			$ 300,000,000	$ 300,000,000
Initial Public Offering | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit				1
Number of warrants in a unit				0.5
Number of shares issuable per warrant				1
Exercise price of warrants				$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units sold	4,500,000			4,500,000
Purchase price, per unit	$ 10			$ 10
Proceeds from issuance initial public offering	$ 45,000,000
Over-allotment option | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units sold	600,000			600,000
Purchase price, per unit	$ 1.50
Proceeds from issuance initial public offering	$ 900,000
Exercise price of warrants				$ 1.50
Over-allotment option | Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Number of units sold	4,500,000
Purchase price, per unit	$ 10

Private Placement (Details)

Private Placement (Details) - Private Placement Warrants - USD ($)	Aug. 03, 2021	Oct. 31, 2020	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of warrants		$ 7,852,500
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrant			$ 1.50
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued			5,235,000
Price of warrants	$ 1.50		$ 11.50
Proceeds from issuance of warrants	$ 900,000		$ 7,852,500
Additional units sold of shares	600,000
Number of shares per warrant			1

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details)	Mar. 31, 2021USD ($)$ / sharesshares	Aug. 31, 2020$ / sharesshares	Jun. 30, 2021USD ($)D$ / sharesshares	Feb. 22, 2021shares	Dec. 31, 2020shares
Related Party Transaction [Line Items]
Number of shares issued			34,500,000
Aggregate purchase price | $			$ 25,000
Class B Common Stock
Related Party Transaction [Line Items]
Common shares, shares outstanding			8,625,000		8,625,000
Founder Shares
Related Party Transaction [Line Items]
Common shares, shares outstanding			8,625,000
Founder Shares | Sponsor
Related Party Transaction [Line Items]
Number of shares issued	50,000	1,990
Share issue price | $ / shares	$ 0.002
Aggregate number of shares owned			34,500,000
Shares subject to forfeiture			2,875,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Restrictions on transfer period of time after business combination completion			1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares			$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination			150 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D			20
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			30 days
Founder Shares | Sponsor | Class B Common Stock
Related Party Transaction [Line Items]
Share issue price | $ / shares		$ 19.90
Common shares, shares outstanding				11,500,000
Founder Shares | Independent Director
Related Party Transaction [Line Items]
Number of shares issued	150,000
Aggregate purchase price | $	$ 300

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Feb. 24, 2021	Dec. 31, 2020	Jun. 30, 2021
Related Party Transaction [Line Items]
Expenses incurred and paid		$ 465	$ 164,476
Due from Sponsor		$ 25,000
Aggregate loan amount	$ 750,000
Interest rate	0.12%
Advances from related party			164,476
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month			$ 16,667

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Aug. 03, 2021	Jul. 13, 2021	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Number of units sold		30,000,000
Deferred fee per unit			$ 0.35
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units sold			5,235,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Underwriting option period			30 days
Number of units sold			30,000,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units sold	4,500,000		4,500,000
Over-allotment option | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units sold	600,000		600,000
Over-allotment option | Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Number of units sold	4,500,000
Underwriters' deferred discount	$ 12,075,000

Stockholders' Equity - Preferre

Stockholders' Equity - Preferred Stock Shares (Details) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Stockholders' Equity
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

Stockholders' Equity - Common S

Stockholders' Equity - Common Stock Shares (Details)	6 Months Ended
	Jun. 30, 2021Vote$ / sharesshares	Dec. 31, 2020Vote$ / sharesshares
Founder Shares
Class of Stock [Line Items]
Common shares, shares outstanding (in shares)	8,625,000
Class A Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	800,000,000	800,000,000
Common shares, shares issued (in shares)	8,625,000
Common shares, shares outstanding (in shares)	8,625,000
Class A Common Stock Not Subject to Redemption
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	800,000,000	800,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, shares issued (in shares)	0	0
Common shares, shares outstanding (in shares)	0	0
Class B Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	199,000,000	199,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1	1
Common shares, shares issued (in shares)	8,625,000	8,625,000
Common shares, shares outstanding (in shares)	8,625,000	8,625,000
Ratio to be applied to the stock in the conversion	20
Common stock subject to redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)	1,125,000

Stockholders' Equity - Warrants

Stockholders' Equity - Warrants (Details)	6 Months Ended
	Jun. 30, 2021D$ / shares
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Minimum threshold written notice period for redemption of public warrants	30 days
Warrants
Class of Warrant or Right [Line Items]
Maximum period after business combination in which to file registration statement	15 days
Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise period condition one	30 days
Warrant exercise period condition two	12 months
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price | $ / shares	$ 18
Redemption price per public warrant (in dollars per share) | $ / shares	$ 0.01
Threshold trading days for redemption of public warrants	20 days
Threshold consecutive trading days for redemption of public warrants | D	30
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Number of trading days on which fair market value of shares is reported | D	30

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Aug. 20, 2021	Jul. 27, 2021	Feb. 24, 2021	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Aggregate loan amount			$ 750,000
Interest rate			0.12%
Sponsor
Subsidiary, Sale of Stock [Line Items]
Aggregate loan amount				$ 300,000,000,000
Sponsor | Subsequent Event [Member]
Subsidiary, Sale of Stock [Line Items]
Aggregate loan amount	$ 800,000	$ 1,200,000
Interest rate	0.14%	0.12%